Please use this identifier to cite or link to this item:
http://ir.mu.ac.ke:8080/jspui/handle/123456789/5980
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Buziba, Nathan | - |
dc.date.accessioned | 2022-02-16T06:34:53Z | - |
dc.date.available | 2022-02-16T06:34:53Z | - |
dc.date.issued | 2018 | - |
dc.identifier.uri | https://pubmed.ncbi.nlm.nih.gov/29946526/ | - |
dc.identifier.uri | http://ir.mu.ac.ke:8080/jspui/handle/123456789/5980 | - |
dc.description.abstract | uberculosis (TB) is a leading cause of childhood mortality. Isoniazid preventive therapy significantly reduces progression to TB disease. The World Health Organization recommends that high TB burden countries conduct child contact management (CCM) to identify exposed child contacts aged <5 years for screening and appropriate treatment. An active, clinic-based CCM strategy incorporating transport/screening reimbursement, monitoring and evaluation tools, and health care worker education was implemented in western Kenya. Among 169 identified child contacts aged <5 years, 146 (86%) underwent successful screening, of whom 43 (29%) were diagnosed with active TB. We describe our CCM strategy and its potential for enhancing screening and treatment efforts. | en_US |
dc.language.iso | en | en_US |
dc.publisher | PubMed | en_US |
dc.subject | Child contact management | en_US |
dc.subject | Isoniazid preventive therapy | en_US |
dc.subject | Pediatric TB | en_US |
dc.title | Implementation of an active, clinic-based child tuberculosis contact management strategy in western Kenya | en_US |
dc.type | Article | en_US |
Appears in Collections: | School of Medicine |
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.